We are live on
!
Find out more
FVFI
Flagship Ventures Fund IV Portfolio holdings
AUM
$382M
This Fund
S&P 500
This Quarter
Est. Return
-24.11%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$382M
AUM Growth
–
Cap. Flow
+$375M
Cap. Flow
% of AUM
98.23%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seres Therapeutics
MCRB
|
+$368M |
| 2 |
TTOO
T2 Biosystems, Inc
TTOO
|
+$6.54M |
| 3 |
CARM
Carisma Therapeutics
CARM
|
+$1.01M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 98.08% |
Similar funds
HC
IUAM
GWM
CK
SHA
SAS
EIM
SHG
Flagship Ventures Fund IV's Q1 2016 Portfolio in Review
Q1 2016 is the first quarter with a 13F filing on record for Flagship Ventures Fund IV, which disclosed 3 positions worth $382M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Seres Therapeutics: 704,179 shares worth $374M.
By sector, the portfolio is most concentrated in Healthcare at 98% of assets.
- Flagship Ventures Fund IV's largest Q1 2016 buy was Seres Therapeutics: 704,179 shares worth $374M.
- Flagship Ventures Fund IV's ten largest holdings make up 100% of its $382M portfolio in Q1 2016.
- Flagship Ventures Fund IV disclosed 3 positions in Q1 2016, its first 13F filing on record.
Based on Flagship Ventures Fund IV's 13F filing for Q1 2016, filed 13 May 2016.